News

AddToAny

Google+ Facebook Twitter Twitter

Under the microscope: Fomitopsis officinalis

This month: Fomitopsis officinalis

What is Fomitopsis officinalis?

A wood-inhabiting parasitic fungus forming distinctive conks that can be more than 50 cm long, hoof-shaped or columnar.

You mean agarikon?

Yes, that is how the fungus is commonly known. Since ancient times it has been used for medical purposes.

I’m guessing that’s why we are looking at it today.

Indeed. It is part of a novel study assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.

OK. Tell me more.

It is a multi-centre study led by University of California San Diego School of Medicine and UCLA, in collaboration with the La Jolla Institute for Immunology. It is among the first to evaluate these integrative medicine approaches using a randomised, double-blind, placebo-controlled clinical trial.

So, what’s the latest?

The trial started in December 2020 and is due to run until December 2022. It will test the safety and feasibility of a 50/50 blend of the mushrooms agarikon (Fomitopsis officinalis) and turkey tail (Trametes versicolor) in capsule form.

Is there any previous evidence? In a preclinical study published in 2019 in Mycology, agarikon was found to inhibit viruses including influenza A(H1N1), influenza A(H5N1) and herpes.

What do the team hope for?

That the mushrooms may inhibit the viruses’ replication – a theory they plan to test in a Phase II trial.

Where can I learn more?

Visit clinicaltrials.gov and search for “MACH-19” for more information.

Related Articles

Memory B cells protecting against mutant viruses

Specialised memory cells found in our immune system play an important role in our ability to fight virus mutations, such as those produced by the SARS-CoV-2 virus, according to research.

“Recovering from covid can take years”

Two years after infection with COVID-19, half of patients who were admitted to hospital still have at least one symptom, according to the longest follow-up study to date.

Lupus: In search of the elusive mutation

Carola Vinuesa explains her research into lupus and what happened when a TLR7 mutation was introduced to mice using CRISPR gene-editing.

“Diabetes in COVID-19 patients may be transitory”

Many COVID-19 patients newly diagnosed with diabetes during hospital admission may in fact have a temporary form of the disease related to the acute stress of the viral infection, it is claimed.

Top